Note: Registration details for this event are pending (depending on travel possibilities for the facilitator). No virtual option.

Stay tuned for updates in August.

PSYCHOLYTIC THERAPY: Theory, Mechanisms and Practical Aspects 

One Day Workshop for Clinicians – SUN, Oct 18, 2020 – 9am – 5pm


This workshop will provide an overview of the historical developments of psycholytic therapy in Europe, with a focus on its psychological and neurophysiological foundations. Psychedelic therapy as established in Canada and the US was never used in Europe. European therapists were eager to use low doses of LSD to activate unconscious conflicts, memories, and archetypes to further therapeutic abreactions and “working through” (as conceptualized by psychoanalytic/psychodynamic therapy).

Workshop facilitator, Torsten Passie, MD, who has more than 30 years of experience with these treatments and the research related to them, will also describe a few case histories, and discuss assessments and evaluations of patients, as well as how indications (or counter indications) can be established. There will be time and space for questions and group discussions regarding specific issues, opportunities and challenges.

At the end of the workshop, participants will be better able to:
  • Compare psycholytic therapy vs psychedelic therapy
  • Describe individual and group approaches (as used in Europe).
  • Describe recent practices of the use of MDMA and LSD in group settings.
  • Apply and understand techniques, processes, precautions and safety guidelines when working with patients in the course of psycholytic therapy.
Schedule: Sun, October 18, 2020 — 9am – 5pm
Student Fee: CAD175 + GST
Regular Fee: CAD225 + GST
6 CE credits (Details TBC)

Torsten Passie MD, PhD is Professor of Psychiatry and Psychotherapy at Hannover Medical School (Germany) and Visiting Scientist at Goethe University in Frankfurt/Main (Germany).

He studied philosophy, sociology (MA) at Leibniz-University, Hannover and medicine at Hannover Medical School. He worked at the Psychiatric University Clinic in Zürich (Switzerland) and with Professor Hanscarl Leuner (Göttingen), the leading European authority on hallucinogens and psycholytic therapy.

From 1998 to 2010 he was a scientist and psychiatrist at Hannover Medical school (Germany) where he researched the addictions and the psychophysiology of altered states of consciousness and their healing potential, including clinical research with hallucinogenic drugs. He is a board member of the Swiss Physicians Society for Psycholytic Therapy and was Visiting Professor at the Harvard Medical School in Boston during the years 2012-2015 . He is a therapist in the Phase 3 studies for MDMA-assisted psychotherapy for PTSD in Europe. More than 50 of his Publications have appeared in high-ranking scientific journals. His books include The Pharmacology of LSD (2010), Healing with Entactogens (2012) and The Science of Microdosing Psychedelics (2019).